APA (7th ed.) Citation

Z, L., J, W., Q, L., Y, L., & Y, Y. (2026). Evolution of the prostate cancer diagnostic paradigm: Integrated evidence and clinical pathways from targeted biopsy to biopsy-free strategy. Frontiers in oncology, 16, 1835580. https://doi.org/10.3389/fonc.2026.1835580

Chicago Style (17th ed.) Citation

Z, Liu, Wu J, Lu Q, Li Y, and Yang Y. "Evolution of the Prostate Cancer Diagnostic Paradigm: Integrated Evidence and Clinical Pathways from Targeted Biopsy to Biopsy-free Strategy." Frontiers in Oncology 16 (2026): 1835580. https://doi.org/10.3389/fonc.2026.1835580.

MLA (9th ed.) Citation

Z, Liu, et al. "Evolution of the Prostate Cancer Diagnostic Paradigm: Integrated Evidence and Clinical Pathways from Targeted Biopsy to Biopsy-free Strategy." Frontiers in Oncology, vol. 16, 2026, p. 1835580, https://doi.org/10.3389/fonc.2026.1835580.